Roger Jeffs A.'s Insider Trades & SAST Disclosures
Roger Jeffs A.'s most recent trade in Axsome Therapeutics Inc was a trade of 1,408 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 21, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Roger Jeffs A..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 1,408 | 1,408 | - | - | Stock Option (Right to Buy) | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2025 | 229,327 | 229,327 | - | - | Performance Stock Units | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2025 | 229,327 | 1,041,520 (3%) | 0% | 0 | Common Stock | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.78 per share. | 11 Jan 2025 | 22,343 | 1,019,177 (3%) | 0% | 11.8 | 263,201 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.11 per share. | 14 Oct 2024 | 8,053 | 812,193 (2%) | 0% | 11.1 | 89,450 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 12.53 per share. | 12 Jul 2024 | 8,053 | 818,932 (2%) | 0% | 12.5 | 100,904 | Common Stock |
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 5,799 | 5,799 | - | - | Stock Option (Right to Buy) | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.58 per share. | 12 Apr 2024 | 8,360 | 826,985 (2%) | 0% | 14.6 | 121,889 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.82 per share. | 18 Mar 2024 | 28,583 | 835,345 (2%) | 0% | 15.8 | 452,183 | Common Stock |
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2024 | 16,976 | 0 | - | - | Stock Option (Right to Buy) | |
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | Sale of securities on an exchange or to another person at price $ 69.70 per share. | 14 Mar 2024 | 16,976 | 120,756 (0%) | 0% | 69.7 | 1,183,261 | Common Stock |
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.53 per share. | 14 Mar 2024 | 16,976 | 137,732 (0%) | 0% | 25.5 | 433,397 | Common Stock |
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | Sale of securities on an exchange or to another person at price $ 69.70 per share. | 14 Mar 2024 | 13,000 | 120,756 (0%) | 0% | 69.7 | 906,126 | Common Stock |
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2024 | 13,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.03 per share. | 14 Mar 2024 | 13,000 | 133,756 (0%) | 0% | 22.0 | 286,390 | Common Stock |
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2024 | 2,347 | 0 | - | - | Stock Option (Right to Buy) | |
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | Sale of securities on an exchange or to another person at price $ 71.61 per share. | 14 Mar 2024 | 2,347 | 120,756 (0%) | 0% | 71.6 | 168,062 | Common Stock |
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.91 per share. | 14 Mar 2024 | 2,347 | 123,103 (0%) | 0% | 29.9 | 70,199 | Common Stock |
| Axsome Therapeutics Inc | Roger Jeffs A. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 1,425 | 1,425 | - | - | Stock Option (Right to Buy) | |
| Liquidia Corp | A. Jeffs Roger | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2024 | 221,338 | 221,338 | - | - | Performance Stock Units | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2024 | 221,338 | 862,143 (3%) | 0% | 0 | Common Stock | |
| Liquidia Corp | A. Roger Jeffs | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 7.16 per share. | 14 Dec 2023 | 139,665 | 640,805 (2%) | 0% | 7.2 | 1,000,001 | Common Stock |
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2023 | 5,681 | 5,681 | - | - | Stock Option (Right to Buy) | |
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 2,082 | 2,082 | - | - | Stock Option (Right to Buy) | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2023 | 15,807 | 207,249 (0%) | 0% | - | Common Stock | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2023 | 15,807 | 0 | - | - | Restricted Stock Unit | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 5.57 per share. | 06 Sep 2022 | 43,820 | 159,827 (0%) | 0% | 5.6 | 243,990 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 4.90 per share. | 31 Aug 2022 | 993 | 116,007 (0%) | 0% | 4.9 | 4,870 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 931,475 | 931,475 | - | - | Non-Qualified Stock Option (right to buy) | |
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2022 | 16,976 | 16,976 | - | - | Stock Option (Right to Buy) | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.53 per share. | 24 May 2022 | 28,000 | 46,595 (0%) | 0% | 3.5 | 98,812 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2022 | 47,423 | 15,807 | - | - | Restricted Stock Unit | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2022 | 47,423 | 207,250 (0%) | 0% | - | Common Stock | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 154,167 | 1,541,667 (5%) | 0% | 0 | Common Stock | |
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 2,347 | 2,347 | - | - | Stock Option (Right to Buy) | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 1,682,827 | 1,763,180 | - | - | Non-Qualified Stock Option (right to buy) | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 63,230 | 63,230 | - | - | Restricted Stock Unit | |
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | Purchase of securities on an exchange or from another person at price $ 37.30 per share. | 19 Nov 2021 | 3,950 | 120,756 (0%) | 0% | 37.3 | 147,350 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2021 | 20,000 | 20,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2021 | 7,325 | 7,325 | - | - | Stock Option (Right to Buy) | |
| Liquidia Corp | Roger A. Jeffs | Director | Purchase of securities on an exchange or from another person at price $ 2.52 per share. | 13 Apr 2021 | 99,206 | 111,706 (0%) | 0% | 2.5 | 249,999 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2021 | 30,353 | 30,353 | - | - | Non-Qualified Stock Option (right to buy) | |
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2021 | 1,463 | 1,463 | - | - | Stock Option (Right to Buy) | |
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2020 | 13,000 | 13,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges